Case Study

Back

Antibiotic Stewardship

Antibiotic Resistance

Reducing Antibiotic Exposure

Core Elements and Programs

Understanding Procalcitonin

Interpreting Procalcitonin Results

Procalcitonin and Other Biomarkers

Sepsis

COVID-19 Pneumonia

Lower Respiratory Tract Infection

Surgical Site Infections

Special Patient Populations Neonatal Elderly Pediatric

Implementation

Quality Considerations

Economic Impact

Learning Center

Procalcitonin FAQs

Case Studies

Educational Portal

About Us

Clear Search

Recent Searches Clear Search History

Choose your country or region
You are choosing to view another site

Global English

US English

Español

Italian

Français

Deutsch

Some products may not be available to you, and indications may differ from your region’s approved use

Back

Continue

PE Cut-Off Case Study

This case study shows how clinically validated unique cut-off ratio avoids unclear, doubtful results in the intermediate zone.

Download now

Share: Facebook Twitter LinkedIn Email

Email Address

First Name

Last Name

Job Role

Specialty

Company/Institution

Country/Region

State

Postal Code

emailpermission

I confirm that I would like to receive marketing and promotional emails about products and services from Thermo Fisher Scientific Inc. and its affiliates.

You may unsubscribe at any time by clicking on the unsubscribe link in any of the marketing communication you receive.

By submitting this form you agree to Thermo Fisher Scientific Inc. Terms of Use and Privacy Notice, including transfer of your personal data to countries outside your country of residence.

I would like a representative to contact me to discuss PCT implementation in my institution.

City

Phone

Send

Clinical Diagnostics | Thermo Fisher Scientific

Global leader in PCT innovation and BRAHMS biomarker development.

Antibiotic Stewardship

Understanding Procalcitonin

Implementation

Economic Impact

Learning Center

FAQs

B·R·A·H·M·S PCT Assays

About Us

Terms & Conditions

Privacy